Research Topic · Peer-Reviewed

SARS

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by SARS-associated coronaviruses, betacoronaviruses that infect the lower respiratory tract and can progress to severe pneumonia and acute respiratory distress. The original SARS-CoV emerged in 2002, and the closely related SARS-CoV-2 eme…

Curated from this journal's research 📚 12 peer-reviewed articles cited Cited 14× across the literature 🔖 ISSN 2641-4538 🗓 Reviewed July 2026

Overview

Severe acute respiratory syndrome (SARS) is a viral respiratory illness caused by SARS-associated coronaviruses, betacoronaviruses that infect the lower respiratory tract and can progress to severe pneumonia and acute respiratory distress. The original SARS-CoV emerged in 2002, and the closely related SARS-CoV-2 emerged in 2019 as the cause of COVID-19; both are enveloped, positive-sense RNA viruses whose spike glycoprotein mediates receptor binding and entry and serves as a key target for diagnostics, vaccines, and evolutionary analysis. Transmission occurs largely through respiratory droplets and close contact, and the high transmissibility and clinical severity of these viruses have made them central concerns of public health, demanding surveillance, molecular characterization of variants, vaccination, and control measures. Research relevant to this area includes the molecular evolutionary characteristics of SARS-CoV-2 based on spike glycoprotein gene analysis, viral kinetics in mild COVID-19 patients under chloroquine regimens, vaccine efficacy and post-vaccination seroprevalence, molecular evolution and pathogenesis of SARS-CoV-2, screening for variants of concern using rapid-antigen-test residual samples, spike-protein effects on interferon and cytokine gene expression, and strategies to generate herd immunity. Such studies span virology, molecular epidemiology, and prevention. The journal publishes peer-reviewed research on SARS coronaviruses, their molecular evolution and pathogenesis, and the public-health response to coronavirus disease.

Research published in this journal

12 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

SARS-CoV-2 affected cells Pathogeny and Therapy

M.R PonizovskiyCorresponding author
Kiev, Ukraine, “Kiev regional p/n hospital”, /Head of “Laboratory Biochemistry and Toxicology”
Exact topic International Journal of Coronaviruses doi:10.14302/issn.2692-1537.ijcv-20-3538

How this research is being cited

The 12 articles above have been cited 14 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on SARS, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Public Health International (ISSN 2641-4538).

Journal editorial board
Javad Javan-Noughabi · United Kingdom Evelyn O Talbott · United States Zainab Taha · United Arab Emirates

This page summarises published research for orientation; it is not medical or professional advice.